[Impact of introducing assisted electronic prescription on paediatric patient safety]

Carla Fernández Oliveira1, Cristina Martínez Roca1, Alejandro Ávila Álvarez2

  • 1Servicio de Farmacia, Complexo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde, A Coruña, España.

Anales De Pediatria
|February 17, 2020
PubMed

Insights

Assisted electronic prescribing significantly reduced medication errors in pediatric patients, decreasing errors by 40% and eliminating serious ones. This technology enhances patient safety in hospitals.

Area of Science:

  • Pediatric patient safety
  • Health informatics
  • Medication error analysis

Background:

  • Limited research exists on assisted electronic prescribing's impact on pediatric patient safety.
  • Medication errors pose a significant risk in healthcare settings, particularly for vulnerable pediatric populations.

Purpose of the Study:

  • To compare medication errors before and after implementing assisted electronic prescribing in a tertiary hospital.
  • To evaluate the effect of assisted electronic prescribing on pediatric patient safety.

Main Methods:

  • A quasi-experimental comparative study analyzed medication errors pre- and post-implementation.
  • All treatment lines were assessed for error type, cause, and point of occurrence.
  • A Delphi study involving healthcare professionals determined the severity of identified errors.

Main Results:

  • Medication errors decreased from 92% of patients (2.8 errors/patient) pre-implementation to 7.2% (0.1 errors/patient) post-implementation.
  • Assisted electronic prescribing resulted in a 40% absolute risk reduction in medication errors.
  • The incidence of serious medication errors dropped to zero post-implementation, with all errors being mild or moderate.

Conclusions:

  • Implementation of assisted electronic prescribing systems significantly reduces medication errors in pediatric care.
  • The integrated systems for prescription, validation, and administration assistance enhance patient safety by minimizing errors and eliminating severe incidents.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
184
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
204
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K